ArticleClinical case reports2025
Antinuclear Autoantibody-Negative Systemic Lupus Erythematosus (SLE): A Reality or Shortcomings of Diagnostics and Interpretation?
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In-depth evaluation of false-positive biological reactions in the syphilis serological diagnosis: a cross-sectional study with two sampling components.Frontiers in cellular and infection microbiology · 2026Article
- Antinuclear Autoantibody-Negative Systemic Lupus Erythematosus (SLE): A Reality or Shortcomings of Diagnostics and Interpretation?Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This letter highlights the critical need for clinicians to understand antinuclear antibody (ANA) testing methodologies and autoantibody specificities to prevent diagnostic errors and accurately applying classification criteria. Anti-Ro52 is an antinuclear antibody whose detection fulfills the 2019 EULAR/ACR classification entry criterion.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.